I. Roch et al., IN-VITRO SCHEDULE-DEPENDENT INTERACTION BETWEEN PACLITAXEL AND VINORELBINE IN A2780 PARENTAL AND MULTIDRUG-RESISTANT HUMAN OVARIAN-CANCER CELL-LINES, International journal of oncology, 11(6), 1997, pp. 1379-1385
Paclitaxel, a taxane, and vinorelbine, a semisynthetic vinca alkaloid
drug, have tubulin as their common intracellular target but inhibit gr
owth by acting with opposed mechanisms of action and binding to differ
ent sites. The purpose of this study was to evaluate in vitro the cyto
toxicity of these two drugs as single agents, in combination and in se
quence, against a human carcinoma ovarian cell line A2780S and its dox
orubicin-resistant subline A2780R. The cell growth inhibitions were de
termined by the MTT assay. The cytotoxic effect of drug combinations a
t the IC50 level were analysed by the isobologram method of Steel and
Peckham. On simultaneous exposure to paclitaxel and vinorelbine, syner
gistic effects were observed in A2780S and A2780R cell lines. On seque
ntial exposure to paclitaxel first followed by vinorelbine or vice ver
sa, a strong antagonistic interaction was observed. These data demonst
rate that the interactions of vinorelbine and paclitaxel are highly sc
hedule-dependent. These findings could have implications for the desig
n of further clinical protocols and suggest that the simultaneous admi
nistration of the two agents may be the most suitable sequence while s
equential administration may be avoided. Further preclinical and clini
cal studies are required to elucidate the relationship between vinorel
bine and paclitaxel with regard to both anti-tumor activity and toxici
ty.